discovery of glp-1 History GLP-1: From to Revolutionary Treatment Mass spectrometry in the development

Procedures After completion of the 16 week treatment period, all participants had an end-of-treatment (EoT) visit (week 17)

Strategies on how to manage these and other side effects are described in more detail here: Figure 3 of this article and Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists

However, the effects of the BASs on GLP-1 secretion are controversial

Giving patients the ability to resume normal activities within a few days, the recovery time for this procedure is significantly less than open heart surgery

Hence, it is important to understand the underlying reason for the right treatment